Pharmacy Report Archives - Page 36 of 150 - Becker's Hospital Review

A refreshed pharmacy chain model? | Top Walgreens leader exits | Hospitals to ration IV fluids after shortage ends | Another drugmaker seeks 340B changes | GLP-1's $411B conundrum

December 2, 2024 BHR Newsletter 1. An opportunity for a refreshed pharmacy chain model Full story 2. GLP-1's $411B conundrum Full story 3. Hospitals to ration IV fluids after shortage ends Full story 4. 3 themes that emerged from Becker's…

Medicare drug price differences: 5 notes | GLP-2s, explained | 40 largest US health systems | Trump taps HHS deputy secretary | 53% of US adults eligible for Ozempic, Wegovy

November 27, 2024 BHR Newsletter 1. Medicare prescription drug pricing variance: 5 things to know Full story 2. HHS invests $44M in 2 pharmaceutical companies Full story 3. GLP-2s, explained Full story 4. Becker's CPO Summit: Get 3 takeaways on tech,…

Potential risks with Singulair: FDA study | Healthcare execs: Recognize pharmacists as providers | Trump + generic drug costs: 5 notes | Medicare urged to cover GLP-1s | Alzheimer's drug trial halted

November 26, 2024 BHR Newsletter 1. Asthma drug linked to severe mental health side effects: FDA study Full story 2. Trump tariffs could drive up generic drug costs: 5 takeaways Full story 3. Controversial Alzheimer's drug trial halted Full story 4.…

NY system enhances med management | Sanofi aims to alter 340B | Fla. plan to import drugs from Canada stalls | Clonazepam recalled over label error | Who can make GLP-1s? 5 notes

November 25, 2024 BHR Newsletter 1. NYC Health + Hospitals to upgrade medication management technology Full story 2. Florida drug importation plan stalls nearly a year after approval Full story 3. Drugmakers, pharmacists battle over who gets obesity drugs: 5 things…

ASHP taps CIO | Bomb cyclone pauses pharmacy services in Wash. | 10 systems seeking pharmacy leaders | NY's plan to curb PBMs | 6 in 10 patients worry over pharmacy deserts

November 21, 2024 BHR Newsletter 1. New York cracks down on PBM drug prices Full story 2. Rising prescription costs, pharmacy closures shape consumer attitudes: Survey Full story 3. ASHP taps chief information officer Full story 4. Rare disease patients…

Systems brace for possible 340B cuts | Hospital pharmacies enter new markets | PBMs sue FTC | 1st brain-injected gene therapy approved | Wash. hospital OKs pharmacy review in settlement

November 20, 2024 BHR Newsletter 1. Health systems brace for possible 340B cuts Full story 2. 1st gene therapy delivered directly into brain approved Full story 3. PBMs sue to stop FTC's case over insulin prices Full story 4. Rare…

Texas system averts 9K vaccine errors | The future of CDC, HHS under Trump | Lilly drug candidate cuts cardio risk by 86% | Generic GLP-1 to enter market in 2025 | Hospitals overhaul C-suites

November 19, 2024 BHR Newsletter 1. Eli Lilly drug cuts genetic form of cholesterol by 86%: Study Full story 2. Layoffs, pay cuts reshape hospital C-suites Full story 3. After averting 9,000 vaccine errors, ISMP awards Texas system Full story…

Hospital Rx safety advances: Leapfrog | 340B rebate challenges, explained | AI in hospital pharmacy: 4 execs | New drug ad rules take effect: 4 notes | 3 IV fluid shortage updates

November 18, 2024 BHR Newsletter 1. Drugmakers' 340B rebate fight, explained Full story 2. Pharmacy leaders explore AI's potential Full story 3. What's driving hospitals' medication safety advances? Full story 4. Ardent Health and MemorialCare are simplifying purchased services —…

The financial cost of drug shortages: Case study | FDA inspectors in short supply | 10 systems seeking pharmacy leaders | FDA rejects full approval of liver disease drug | Mounjaro helps 99% of prediabetes patients: Study

November 14, 2024 BHR Newsletter 1. FDA struggles to retain inspectors: GAO Full story 2. Mounjaro lowers Type 2 diabetes risk in phase 3 trial: Study Full story 3. The financial burden of drug shortages: 7 study takeaways Full story…

J&J renews push for 340B rebates | What retail pharmacy closures mean for hospitals | Kaiser posts $608M Q3 loss, cites high pharmacy costs | Inova cuts daily IV fluid use in half | Pros, cons to ambulatory pharmacies

November 13, 2024 BHR Newsletter 1. What retail pharmacy closures spell for healthcare Full story 2. J&J sues government over 340B rebate plan Full story 3. Hospital operator plans to sell 10 of 16 hospitals Full story 4. Pharmacy-HR collaboration…